戻る
「早戻しボタン」を押すと検索画面に戻ります。

今後説明を表示しない

[OK]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 ed to contribute to the development of human diabetic autonomic neuropathy.
2 y a role in the pathogenesis of experimental diabetic autonomic neuropathy.
3 G which is relatively spared in experimental diabetic autonomic neuropathy.
4 ing GSK3beta as a new therapeutic target for diabetic autonomic neuropathy.
5 remain potential pathogenetic mechanisms for diabetic autonomic neuropathy.
6  idiopathic gastrointestinal dysmotility, or diabetic autonomic neuropathy (9 percent), and in none o
7 hat may have implications for both long-term diabetic autonomic neuropathies and insulin-induced hypo
8                                              Diabetic autonomic neuropathy and endothelial dysfunctio
9 ries, which could elucidate the link between diabetic autonomic neuropathy and stroke.
10                                              Diabetic autonomic neuropathy (DAN) has been invoked as
11                                              Diabetic autonomic neuropathy (DAN) may impact the BM, b
12                                The classical diabetic autonomic neuropathy (DAN) that eventually occu
13                             In subjects with diabetic autonomic neuropathy (DAN), distal left ventric
14  increased morbidity and mortality in severe diabetic autonomic neuropathy (DAN).
15 ganglion neuritic dystrophy, the hallmark of diabetic autonomic neuropathy in mouse prevertebral symp
16                                              Diabetic autonomic neuropathy is associated with an impa
17 and neuronal degeneration characteristic for diabetic autonomic neuropathy is minor.
18                                              Diabetic autonomic neuropathy results in significant mor
19  The striking improvement in the severity of diabetic autonomic neuropathy shown with IGF-I treatment
20 ly part of a larger disease process, such as diabetic autonomic neuropathy, traumatic brain injury, a
21 thesis in an in vivo streptozotocin model of diabetic autonomic neuropathy using an unbiased counting
22               To address the pathogenesis of diabetic autonomic neuropathy, we have examined the symp
23 tion in the areas of diabetic amyotrophy and diabetic autonomic neuropathy will also be reviewed.

WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。